Status:
UNKNOWN
Antibiotic Treatment of Multiple Erythema Migrans
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Multiple Erythema Migrans
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the efficacy and safety of 15-day ceftriaxone versus 15-day doxycycline treatment in patients with multiple erythema migrans.
Eligibility Criteria
Inclusion
- multiple erythema migrans in patients \> 15 years
Exclusion
- a history of Lyme borreliosis in the past
- pregnancy or lactation
- immunocompromised status
- serious adverse event to doxycycline or beta lactam antibiotic
- taking antibiotic with antiborrelial activity within 10 days
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01163994
Start Date
June 1 2010
End Date
October 1 2017
Last Update
May 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UMC Ljubljana, Department of Infectious Diseases
Ljubljana, Slovenia, 1525